Chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans, major components of the
central nervous system, have the potential to interact with a wide range of growth factors and …

Neonatal ischemic brain injury causes permanent motor-deficit cerebral palsy. Hypoxic–
ischemic encephalopathy (HIE) is a very serious condition that can result in death and …

Perinatal hypoxic ischemic encephalopathy (HIE) results in serious neurological dysfunction
and mortality. Clinical trials of multilineage-differentiating stress enduring cells (Muse cells) …

Chondroitin sulfate proteoglycans (CSPGs) play a pivotal role in many neuronal growth
mechanisms including axon guidance and the modulation of repair processes following …

Perinatal hypoxic-ischemic (HI) brain injury occurs in 1 in 1,000 live births and remains the
main cause of neurological disability and death in term infants. Cytotherapy has recently …

Neurodegenerative disorders, chronic diseases that can severely affect the patient's daily
life, include amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's …

This study aimed to investigate whether the administration of mononuclear cells derived
from human umbilical cord blood cells (UCBCs) could ameliorate hypoxic-ischemic brain …

Currently, adipose-derived mesenchymal stromal/stem cells (ADMSCs) are recognized as a
highly promising material for stem cell therapy due to their accessibility and safety. Given the …

Increasing evidence has suggested that human umbilical cord blood cells (hUCBC) have a
favorable effect on hypoxic–ischemic (HI) brain injury. However, the efficacy of using …

Hypoxic-ischemic encephalopathy (HIE) is a major cause of acute neonatal brain injury and
can lead to disabling long-term neurological complications. Treatment for HIE is limited to …